Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis | Zendy

Marianna Fontana | Zendy; Silvia Pica | Zendy; Patricia Réant | Zendy; Amna AbdelGadir | Zendy; Thomas A. Treibel | Zendy; Sanjay M Banypersad | Zendy; Viviana Maestrini | Zendy; William Barcella | Zendy; Stefania Rosmini | Zendy; Heerajnarain Bulluck | Zendy; Rabya Sayed | Zendy; Ketna Patel | Zendy; Shameem Mamhood | Zendy; Chiara BucciarelliDucci | Zendy; Carol Whelan | Zendy; Anna S Herrey | Zendy; Helen J. Lachmann | Zendy; Ashutosh D. Wechalekar | Zendy; Charlotte Manisty | Zendy; Eric B. Schelbert | Zendy; Peter Kellman | Zendy; Julian D. Gillmore | Zendy; Philip N. Hawkins | Zendy; James Moon | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis

Author(s) -

Marianna Fontana,

Silvia Pica,

Patricia Réant,

Amna AbdelGadir,

Thomas A. Treibel,

Sanjay M Banypersad,

Viviana Maestrini,

William Barcella,

Stefania Rosmini,

Heerajnarain Bulluck,

Rabya Sayed,

Ketna Patel,

Shameem Mamhood,

Chiara BucciarelliDucci,

Carol Whelan,

Anna S Herrey,

Helen J. Lachmann,

Ashutosh D. Wechalekar,

Charlotte Manisty,

Eric B. Schelbert,

Peter Kellman,

Julian D. Gillmore,

Philip N. Hawkins,

James Moon

Publication year - 2015

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.115.016567

Subject(s) - medicine , cardiac amyloidosis , amyloidosis , hazard ratio , ejection fraction , magnetic resonance imaging , transthyretin , cardiology , asymptomatic , al amyloidosis , confidence interval , extracellular fluid , heart failure , radiology , extracellular , antibody , immunoglobulin light chain , biology , immunology , microbiology and biotechnology

The prognosis and treatment of the 2 main types of cardiac amyloidosis, immunoglobulin light chain (AL) and transthyretin (ATTR) amyloidosis, are substantially influenced by cardiac involvement. Cardiovascular magnetic resonance with late gadolinium enhancement (LGE) is a reference standard for the diagnosis of cardiac amyloidosis, but its potential for stratifying risk is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research